Differential proteomic serum pattern of low molecular weight proteins expressed by adenocarcinoma lung cancer patients.
about
High circulating activin A level is associated with tumor progression and predicts poor prognosis in lung adenocarcinoma.Detection of oesophageal cancer biomarkers by plasma proteomic profiling of human cell line xenografts in response to chemotherapy.Surface engineering on mesoporous silica chips for enriching low molecular weight phosphorylated proteinsIntegrative proteomic analysis of serum and peritoneal fluids helps identify proteins that are up-regulated in serum of women with ovarian cancerTransthyretin as a potential biomarker for the differential diagnosis between lung cancer and lung infection.Identification of isocitrate dehydrogenase 1 as a potential diagnostic and prognostic biomarker for non-small cell lung cancer by proteomic analysis.Comparative proteomic approach identifies PKM2 and cofilin-1 as potential diagnostic, prognostic and therapeutic targets for pulmonary adenocarcinomaIntegrative proteomics and tissue microarray profiling indicate the association between overexpressed serum proteins and non-small cell lung cancerLung cancer proteomics: recent advances in biomarker discoverySerum proteomics and disease-specific biomarkers of patients with advanced gastric cancer.Gene promoter methylation assayed in exhaled breath, with differences in smokers and lung cancer patients.Update on biomarkers for the detection of lung cancer.Quantification of Serum Proteins of Metastatic Oral Cancer Patients Using LC-MS/MS and iTRAQ LabelingIdentification of 10 Candidate Biomarkers Distinguishing Tuberculous and Malignant Pleural Fluid by Proteomic Methods.Current and Prospective Protein Biomarkers of Lung Cancer.Itraconazole treatment of primary malignant melanoma of the vagina evaluated using positron emission tomography and tissue cDNA microarray: a case report.
P2860
Q27853357-CF408FE7-BB8D-4EDA-918A-A5C5FBA02811Q33605656-E6A61D05-914D-4FE0-AD04-C6F192FF1609Q33764263-5342E8B6-341A-4D38-8D62-A96247A03F4CQ33915144-79EB86A7-34F8-4C2A-A426-463A3722D064Q33932016-08082E89-0150-4939-81A1-3283C1001A11Q34069325-19BA00A0-19F7-46E6-AC24-4E72351C6CA0Q34075588-3812FB54-9C43-45D5-8AC0-B830090330D9Q34532251-3FE6EA0B-6FEA-438E-ACCA-0059210400EEQ35389059-EC78718C-2F9A-4BC9-B653-5EFDA63B7B6AQ36216932-43BFFAB9-7AFA-415B-9AC1-F33A842B387DQ37382420-D09CF2E0-5E50-4730-998E-306814ECBD48Q37645219-92641A62-CCD0-4824-887D-AE6FE2C07188Q40609252-3E910534-BB92-4776-8B82-C05CEDAFEE5BQ42646980-D2CE5B10-4854-4FD8-BDB0-25CA992FC3CAQ47130839-A4983539-1EBC-4E56-A209-4CA18C64C9D9Q55489012-03EA4BB4-D8D4-40D8-9C06-D8BA60D33E18
P2860
Differential proteomic serum pattern of low molecular weight proteins expressed by adenocarcinoma lung cancer patients.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Differential proteomic serum p ...... arcinoma lung cancer patients.
@ast
Differential proteomic serum p ...... arcinoma lung cancer patients.
@en
type
label
Differential proteomic serum p ...... arcinoma lung cancer patients.
@ast
Differential proteomic serum p ...... arcinoma lung cancer patients.
@en
prefLabel
Differential proteomic serum p ...... arcinoma lung cancer patients.
@ast
Differential proteomic serum p ...... arcinoma lung cancer patients.
@en
P2093
P1476
Differential proteomic serum p ...... arcinoma lung cancer patients.
@en
P2093
Carla Mendes Maciel
Gilberto Barbosa Domont
Magno Junqueira
Marcia Tie Kawamura
Marcos Eduardo Machado Paschoal
Maria da Glória da Costa Carvalho
Ricardo Luiz Menezes Duarte
P577
2005-01-01T00:00:00Z